A versatile automated pipeline for quantifying virus infectivity by label-free light microscopy and artificial intelligence.
Anthony PetkidisVardan AndriasyanLuca MurerRomain VolleUrs F GreberPublished in: Nature communications (2024)
Virus infectivity is traditionally determined by endpoint titration in cell cultures, and requires complex processing steps and human annotation. Here we developed an artificial intelligence (AI)-powered automated framework for ready detection of virus-induced cytopathic effect (DVICE). DVICE uses the convolutional neural network EfficientNet-B0 and transmitted light microscopy images of infected cell cultures, including coronavirus, influenza virus, rhinovirus, herpes simplex virus, vaccinia virus, and adenovirus. DVICE robustly measures virus-induced cytopathic effects (CPE), as shown by class activation mapping. Leave-one-out cross-validation in different cell types demonstrates high accuracy for different viruses, including SARS-CoV-2 in human saliva. Strikingly, DVICE exhibits virus class specificity, as shown with adenovirus, herpesvirus, rhinovirus, vaccinia virus, and SARS-CoV-2. In sum, DVICE provides unbiased infectivity scores of infectious agents causing CPE, and can be adapted to laboratory diagnostics, drug screening, serum neutralization or clinical samples.
Keyphrases
- artificial intelligence
- deep learning
- sars cov
- label free
- machine learning
- convolutional neural network
- big data
- endothelial cells
- high throughput
- single cell
- high resolution
- cell therapy
- high glucose
- drug induced
- emergency department
- respiratory syndrome coronavirus
- optical coherence tomography
- disease virus
- single molecule
- induced pluripotent stem cells
- high density
- gene therapy
- high speed
- respiratory tract